The biomedical model has failed! So what's next?

Contemporary Urology

Volumn 18, Issue 7, 2006, Pages 31-39

  Nickel, J Curtis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845783735     PISSN: 10422250     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Collins MM, Stafford RS, O'Leary MP, et al. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159(4):1224-1228.
2. Nickel JC, Teichman JM, Gregoire M, et al. The prevalence, diagnosis, characterization and treatment of prostatitis, interstitial cystitis and epididymrtis in out-patient urological practice: The Canadian PIE study. Urology. 2005;66(5):935-940.
3. Nickel JC. Prostatitis: myths and realities. Urology. 1998;51(3):362-366.
4. Krieger JN, Nyberg LJ, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236-237.
5. Litwin MS, McNaughton-Collins M, Fowler FJ, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol. 1999;162(2):369-375.
6. McNaughton-Collins M, Wang Y, Propert KP, et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006;15(2):299-305.
7. Nickel JC, McNaughton-Collins M, Litwin SM. Use of a validated outcome measure for prostatitis. J Clin Outcomes Manage. 2001;8:30-37.
8. Schaeffer AJ, Knauss JS, Landis, JR, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: The NIH chronic prostatitis cohort (CPC) study. J Urol. 2002;168(3):1048-1053.
9. True LD, Berger RE, Rothman I, et al. Prostate histopathology in chronic prostatitis/chronic pelvic pain syndrome, a prospective biopsy study. J Urol. 1999;162:2014-2018.
10. Nickel JC, Bostwick DG, Sommerville MC, et al. Lack of relationship between clinical prostatitis and prostate inflammation: baseline data from the REDUCE trial. J Urol. 2006;175(4):31-32. Abstract 97.
11. Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol. 2003;170(3):818-822.
12. Nickel JC. The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-infammatories. What is the evidence? BJU Int. 2004;94(9):1230-1233.
13. Nickel JC, Berger R, Pontari M. Changing paradigms for chronic pain: a report from the Chronic Pelvic Pain/Chronic Prostatitis Scientific Workshop October 19-21, 2005 Baltimore, Maryland. Rev Urol. 2006;8(1):28-35.
14. Meares EM Jr, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol. 1968;5:492-518.
15. Nickel JC, Wang Y, Shoskes D et al. Validation of the pre and post massage test (PPMT) for the evaluation of the patient with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). J Urol. 2005;173(4):S29.
16. Nickel JC. Chronic prostatitis/chronic pelvic pain syndrome: a decade of change. AUA Update Series, 2006. In press.
17. Alexander RB, Propert KJ, Schaeffer AJ, et al. Chronic Prostatitis Collaborative Research Network. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med. 2004;141(8):581-589.
18. Nickel JC, Downey J, Clark J, et al. Levofloxacin treatment for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men: a randomized placebo controlled multi-center trial Urology. 2003;62(4):614-617.
19. Nickel JC, Downey J, Johnston B, et al. Predictors of patient response to antibiotic therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective muliticenter clinical trial. J Urol. 2001;165(5):1539-1544.
20. Nickel J Curtis, Zadeikis N, Spivey M, et al. Clinical significance of anti-microbial therapy in chronic prostatitis associated with non-traditional uropathogens. J Urol. 2005;173(4):S30.
21. Nickel JC, Narayan P, MacKay J, et al. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol. 2004;171(4):1594-1597.
22. Cheah PY, Liong ML, Yuen KH, et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol. 2003;169(2):592-596.
23. Mehik A, Alas P, Nickel JC, et al. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind placebo controlled, pilot study. Urology. 2003;62(3):425-429.
24. Nickel JC, Pontari M, Moon T, et al. A randomized, placebo controlled multi-center study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic non-bacterial prostatitis. J Urol. 2003;169:1401-1405.
25. Goldmeier D, Madden P, McKenna M, et al. Treatment of category IIIA prostatitis with zafirlukast: a randomized controlled feasibility study. Intern J STD & AIDS. 2005;16:196-200.
26. Nickel JC, Downey J, Pontari MA, et al. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIa chronic nonbacterial prostatitis). BJU Int. 2004;93(7):991-995.
27. Nickel JC, Johnston, Downey J, et al. Pentosanpolysulfate therapy for chronic nonbacterial prostatitis (chronic plevic pain syndrome category IIIA): a prospective multicenter clinical trial. Urology. 2000;56:413-417.
28. De Rose AF, Gallo F, Giglio M, et al. Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology. 2004;63(1):13-16.
29. Shoskes DA, Zeitlin SI, Shahed A et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo control trial. Urology. 1999;54(6):960-963.
30. Reissigl A, Djavan B, Pointner J. Prospective placebo-controlled multicenter trial on safety and efficacy of phytotherapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome. J Urol. 2004;171(4 suppl);61. Abstract 233.
31. Schneider H, Ludwig M, Horstmann A, et al. The efficacy of cemilton® in patients with chronic pelvic pain syndrome (CP/CPPS) type NIH IIIA: a randomized, prospective, double-blind, placebo controlled study. J Urol. 2006;175(4 suppl):34. Abstract 105.
32. Elist J. Effects of pollen extract preparation Prostat/Poltit on lower urinary symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized, double-blind, placebo-controlled study. Urology. 2006;67:60-63.